NORDeHEALTH aims to implemented to give patients online access to their electronic health records (PAEHR) and increase self-management and transparencyin healthcare. The goal is to enable further digitalization of the public health sector by providing concrete feedback to the national. authorities in the respective countries, provide guidelines and frameworks for design, implementation and evaluation of personal eHealthservices (PeHS).
The aims of the ALLTogether study are to improve survival and quality of survival for children and young adults with ALL. ALL in young people has excellent outcome with >90% survival in children and about 75% in young adults. However, patients still die of diseases after relapse as a result of under-treatment.
Rheumatoid arthritis (RA, life-time risk around 2%) entails a considerable burden for affected individuals (pain, reduced life-span, reduced function, reduced quality of life), for health-care, and for society (reduced work ability, and treatment costs that currently accounts for almost 10% of the total drug expenditure). Delayed or ineffective treatment leads to joint destruction, co-morbidities, and increased mortality.v
The PERAID project proposes to implement personalized medicine (PM) in severe infectious diseases, specifically focusing on the life-threatening necrotizing soft tissue infections (NSTI) as well as the large heterogeneous group of sepsis patients.
Globally, the leading cause of years of life lost is ischemic heart disease (IHD). In the EU 13.2 mio. patients are diagnosed with IHD(1) of these 700,000 live in the Nordic countries. IHD causes chest pain, myocardial infarcts, reduced physical capacity and reduces life-expectance. IHD is considered a chronic disease and may progress despite current optimal treatment.
The NORDTREAT project will build on the achievements within recent large-scale European initiatives that includes cross-disciplinary collaborations between academia, hospitals, biomedical companies and patient organisations. The overall aim is to improve Inflammatory bowel disease (IBD) patients' prognosis and quality of life by introducing a novel personalized medicine algorithm that is based on recently generated -omics data.
Sleep apnea is a prevalent nocturnal breathing disorder and causes a high burden to the affected individuals, as well as to society and economy. However, current diagnostic methods for sleep apnea are complicated and labour-intensive processes involving various shortcomings related to measuring, analysing and reporting of data.
As the most commonly diagnosed malignancy and the 2nd leading cause of cancer-related death in men, prostate cancer (PC) is a major health care problem in the Nordic countries, where incidences will rise by 40% in the next 20-ys due to population aging.